Company / FCF Margin
Crinetics Pharmaceuticals, Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-4985.5%
FY2025
5-year range
-22525.3% / -2467.0%
FY2021-FY2025
Trend
+77.9%
vs FY2024
Sector context
#131 of 134
Health Care
What the data says
Among 134 Health Care companies, Crinetics Pharmaceuticals, Inc. is in the bottom 2% for fcf margin. FCF Margin has fluctuated over the past 8 years, ranging from -22525.3% in FY2024 to -478.4% in FY2019.
Based on SEC 10-K filings.
-4985.5% in FY2025 with a 5-year CAGR of -4140.4%.
Declined from -2467.0% to -4985.5% over the past 3 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -2518.5pp
- 5-Year Change
- -4140.4pp
- 10-Year Change
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 134This company -4985.5% Sector average -637.8%
▼
-681.7% below sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 77.9% year-over-year.
- Currently 4347.7pp below the Health Care sector average.
- Peak fcf margin was recorded in FY2019.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4985.5% | +77.9% |
| FY2024 | -22525.3% | - |
| FY2023 | - | - |
| FY2022 | -2467.0% | +70.1% |
| FY2021 | -8258.3% | -877.2% |
| FY2020 | -845.1% | -76.6% |
| FY2019 | -478.4% | +50.2% |
| FY2018 | -960.6% | - |
| FY2017 | - | - |
| FY2016 | -960.6% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026